Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Lumiera Health Inc.
  6. News
  7. Summary
    NHP   CA5502541066

LUMIERA HEALTH INC.

(NHP)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Lumiera Health : announces the results of its annual meeting

07/06/2021 | 06:37pm EDT

MONTREAL, July 6, 2021 /CNW Telbec/ - Lumiera Health Inc.  (TSXV: NHP) (the "Company" or "Lumiera "), a company specializing in the development and commercialization of natural health products, is pleased to announce the results of its annual general and special meeting of shareholders (the "Meeting"), which was held June 30, 2021 by webcast. All of the nominees listed in the Company's management information circular dated May 21, 2021, were elected as directors.

Detailed results of the vote for the election of directors are set out below:

Nominee

VoteFOR 

%FOR   

VoteWithheld

%Withheld

Marie Bélanger

54,911,018

99.57%

238,750

0.43

Kevin Cole

46,127,089

83.64%

9,022,679

16.36

Nathalie Nasseri

54,911,018

99.57%

238,750

0.43

Carlos Ponce

46,127,089

83.64%

9,022,679

16.36

Simon Castonguay

46,127,089

83.64%

9,022,679

16.36

All other matters presented for shareholder approval at the Meeting were approved, as follows:

  • to appoint Richter LLP, Chartered Accountants as the auditors of the Corporation and to authorize the directors to fix the auditors' remuneration;
  • to consider, and if deemed advisable, to pass, with or without variation, an ordinary resolution confirming re-approval of the Corporation's incentive stock option plan;

About Lumiera Health Inc.

Lumiera specializes in the development and commercialization of natural health products for the healthcare industry. The Company sells both oral and topical botanical agents to help manage unmet medical needs through its Holizen Laboratories division. Lumiera is also developing and commercializing a unique portfolio of products acting on the endocannabinoid system and providing innovative solutions for chronic pain and inflammation. The Company is a pioneer in the health and pain management innovation space and the Lumiera brand is rooted in the core brand values of science, nature and compassion.  Passionate about making people feel better, we deliver trustworthy and scientifically proven solutions that work with the body's own system.

For more information visit: www.lumiera.ca.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking information

Certain statements contained in this press release constitute "forward-looking information" as such term is defined in applicable Canadian securities legislation. The words "may", "would", "could", "should", "potential", "will", "seek", "intend", "plan", "anticipate", "believe", "estimate", "expect" and similar expressions indicate such "forward-looking information" as they relate to Lumiera. All statements other than statements of historical fact may be forward-looking information. Such statements reflect Lumiera' current views and intentions with respect to future events, and current information available to Lumiera, and are subject to certain risks, uncertainties and assumptions. Such risks and uncertainties include, among others, the risk factors included in Lumiera' annual management's discussion and analysis for the year ended November 30, 2020, which is available under the issuer's SEDAR profile at www.sedar.com.  Material factors or assumptions were applied in providing forward-looking information. Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. Should any factor affect Lumiera in an unexpected manner, or should assumptions underlying the forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, Lumiera does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and Lumiera undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law.

SOURCE Lumiera Health Inc.

© Canada Newswire, source Canada Newswire English

All news about LUMIERA HEALTH INC.
09/14LUMIERA HEALTH : announces Private Placement Extension
AQ
08/23LUMIERA HEALTH : begins sales of Awaye pain relief cream on Amazon marketplace
AQ
08/20LUMIERA HEALTH : to Sell Awaye Pain Relief Cream on Amazon Platform
MT
08/20LUMIERA HEALTH : begins sales of Awaye™ pain relief cream on Amazon market..
AQ
08/20Lumiera Health Begins Sales of Awaye Pain Relief Cream on Amazon Marketplace
CI
08/17MARKET CHATTER : BHP Quits Oil, Piles Into Canadian Potash In Overhaul For CEO H..
MT
08/09LUMIERA HEALTH : announces proposed $900,000 Private Placement
AQ
08/06LUMIERA HEALTH : Seeks C$0.9 Million in a Private Placement of Share Units
MT
08/06LUMIERA HEALTH : announces proposed $900,000 Private Placement
AQ
08/06Lumiera Health Inc. announced that it expects to receive CAD 0.9 million in f..
CI
More news
Financials
Sales 2020 0,50 M 0,39 M 0,39 M
Net income 2020 -1,93 M -1,51 M -1,51 M
Net cash 2020 0,99 M 0,77 M 0,77 M
P/E ratio 2020 -1,90x
Yield 2020 -
Capitalization 4,55 M 3,57 M 3,56 M
EV / Sales 2019 18,8x
EV / Sales 2020 8,71x
Nbr of Employees -
Free-Float 68,0%
Chart LUMIERA HEALTH INC.
Duration : Period :
Lumiera Health Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Carlos Ponce Chief Executive Officer
Mario Paradis Chief Financial Officer
Kevin Cole Chairman
Richard Giguere Vice President-Commercial Operations
Sector and Competitors
1st jan.Capi. (M$)
LUMIERA HEALTH INC.-25.00%4
JOHNSON & JOHNSON4.68%433 701
ROCHE HOLDING AG10.97%321 442
PFIZER, INC.20.81%246 078
NOVO NORDISK A/S50.80%232 556
ELI LILLY AND COMPANY36.28%208 604